Here's why this high-potential growth stock with defensive operations has the potential to see a major rally in 2026. The ...

WELL trades at a FY25 normalized P/E of 9.4, despite ~55% topline growth and triple digit EBITDA growth. WELL has multiple re-rate catalysts including WELLSTAR's planned IPO and potential US asset ...

About WELL Health Technologies Corp. WELL Health Technologies Corp. operates as digital healthcare company, which engages in owning and operating a portfolio of primary healthcare facilities. Its ...

Fintel reports that on December 8, 2025, STIFEL CANADA maintained coverage of WELL Health Technologies (OTCPK:WHTCF) with a Buy recommendation. As of December 6, 2025, the average one-year price ...

Fintel reports that on December 12, 2025, PARADIGM CAPITAL maintained coverage of WELL Health Technologies (OTCPK:WHTCF) with a Buy recommendation. As of December 6, 2025, the average one-year price ...